1. Home
  2. Insider Trading Stock Activity
  3. Yu Yong
Yu Yong

Yu Yong

SVP, Clinical Development of GNLX

VP, Clinical Trial Operations of GNLX

Stock Insider Trading Activity of Yu Yong

Yu Yong

SVP, Clinical Development

Sell
GNLX Nov 17, 2025

Avg Cost/Share

$5.37

Shares

973

Total Value

$5,224.43

Owned After

145,844

SEC Form 4

Yu Yong

SVP, Clinical Development

Sell
GNLX Aug 21, 2025

Avg Cost/Share

$3.36

Shares

3,219

Total Value

$10,807.47

Owned After

145,844

SEC Form 4

Yu Yong

VP, Clinical Trial Operations

Sell
GNLX May 12, 2025

Avg Cost/Share

$2.92

Shares

5,579

Total Value

$16,290.68

Owned After

145,844

SEC Form 4

Yu Yong

VP, Clinical Trial Operations

Sell
GNLX Feb 19, 2024

Avg Cost/Share

$2.12

Shares

6,849

Total Value

$14,519.88

Owned After

145,844

SEC Form 4

Yu Yong

VP, Clinical Trial Operations

Sell
GNLX Dec 15, 2023

Avg Cost/Share

$13.56

Shares

32,535

Total Value

$428,179.82

Owned After

145,844

Yu Yong

VP, Clinical Trial Operations

Sell
GNLX Dec 7, 2023

Avg Cost/Share

$11.85

Shares

36,800

Total Value

$435,995.36

Owned After

145,844

SEC Form 4

Yu Yong

VP, Clinical Trial Operations

Sell
GNLX Nov 17, 2023

Avg Cost/Share

$12.15

Shares

18,135

Total Value

$210,430.99

Owned After

145,844

Yu Yong

VP, Clinical Trial Operations

Sell
GNLX Oct 24, 2023

Avg Cost/Share

$19.11

Shares

5,200

Total Value

$99,351.20

Owned After

145,844

SEC Form 4

Share on Social Networks: